Evidence map›Paper›PMID 40981278›Full record

ReviewAntibodies (Basel, Switzerland)2025

Monoclonal Antibodies and Small-Molecule Therapies for Lichen Planus: Targeted Immunomodulation and Emerging Evidence.

Francois Rosset, Nadia Sciamarrelli, Luca Mastorino, Valentina Pala, Sara Boskovic, Eleonora Bongiovanni, Orsola Crespi, Yingying Liao, Simone Ribero, Pietro Quaglino

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Antibodies (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Francois RossetSchool of Dermatology and Venereology, Department of Medical Sciences, University of Turin, 10126 Torino, Italy.ORCID 0000-0002-1655-0395
Nadia SciamarrelliSchool of Dermatology and Venereology, Department of Medical Sciences, University of Turin, 10126 Torino, Italy.
Luca MastorinoSchool of Dermatology and Venereology, Department of Medical Sciences, University of Turin, 10126 Torino, Italy.ORCID 0000-0001-7386-3219
Valentina PalaSchool of Dermatology and Venereology, Department of Medical Sciences, University of Turin, 10126 Torino, Italy.ORCID 0000-0002-3504-2417
Sara BoskovicSchool of Dermatology and Venereology, Department of Medical Sciences, University of Turin, 10126 Torino, Italy.
Eleonora BongiovanniSchool of Dermatology and Venereology, Department of Medical Sciences, University of Turin, 10126 Torino, Italy.ORCID 0009-0007-1915-9993
Orsola CrespiSchool of Dermatology and Venereology, Department of Medical Sciences, University of Turin, 10126 Torino, Italy.ORCID 0009-0001-9270-1204
Yingying LiaoSchool of Dermatology and Venereology, Department of Medical Sciences, University of Turin, 10126 Torino, Italy.
Simone RiberoSchool of Dermatology and Venereology, Department of Medical Sciences, University of Turin, 10126 Torino, Italy.ORCID 0000-0002-0098-1406
Pietro QuaglinoSchool of Dermatology and Venereology, Department of Medical Sciences, University of Turin, 10126 Torino, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autoimmune skin diseasebiologic therapyIL-17immune modulationJAK inhibitorslichen planusmonoclonal antibodiesprecision medicinetargeted immunotherapyTNF-alpha

Identifiers

PMID40981278
PMCPMC12452788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.